FDA Approvals - Accutest obtains 21st US FDA bio study approval (PharmaBiz) Accutest
Accutest obtains 21st US FDA bio study approval (PharmaBiz)
Accutest Research Laboratories Pvt Ltd, the Mumbai based independent Contract Research Organisation (CRO), announced that the company has received its 21st approval for bio-study from US FDA. With this, the company claims that it has owned the largest number of FDA approvals as an Indian CRO.
Nventa Consolidates Offices Into San Diego (FinanzNachrichten)
SAN DIEGO, CA, May 31 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation ( Nachrichten ) (TSX:NVN) ("Nventa" or the "Company") today announced that it plans to consolidate its offices into its San Diego facility and will close its Victoria operations effective approximately June 29, 2007. This consolidation enhances operational efficiencies as the Company advances HspE7, its lead ...
Advanced Cell Technology Enters Into Letter of Intent to Acquire Mytogen, Inc. And Proceed With the Human Clinical ... (RedNova)
Advanced Cell Technology, Inc. (OTCBB:ACTC) today announced that it has entered into a letter of intent to acquire Mytogen, Inc. and its Myoblast Program for the treatment of heart failure.